Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 3, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 2, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 23, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 22, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 19, 2014View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-89

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information